ARQT Annual D&A
$1.52 M
+$587.00 K+62.85%
31 December 2023
Summary:
As of January 23, 2025, ARQT annual depreciation & amortization is $1.52 million, with the most recent change of +$587.00 thousand (+62.85%) on December 31, 2023. During the last 3 years, it has risen by +$1.40 million (+1146.72%). ARQT annual D&A is now at all-time high.ARQT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT Quarterly D&A
$1.43 M
+$1.08 M+307.98%
30 September 2024
Summary:
As of January 23, 2025, ARQT quarterly depreciation & amortization is $1.43 million, with the most recent change of +$1.08 million (+307.98%) on September 30, 2024. Over the past year, it has increased by +$1.04 million (+270.03%). ARQT quarterly D&A is now at all-time high.ARQT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT TTM D&A
$2.53 M
+$1.04 M+70.56%
30 September 2024
Summary:
As of January 23, 2025, ARQT TTM depreciation & amortization is $2.53 million, with the most recent change of +$1.04 million (+70.56%) on September 30, 2024. Over the past year, it has increased by +$1.04 million (+70.33%). ARQT TTM D&A is now at all-time high.ARQT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARQT Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.9% | +270.0% | +70.3% |
| 3 y3 years | +1146.7% | +270.0% | +70.3% |
| 5 y5 years | +100.0% | +270.0% | +70.3% |
ARQT Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +235.0% | at high | +952.9% | at high | +456.4% |
| 5 y | 5-year | at high | +2136.8% | at high | +5866.7% | at high | +3614.7% |
| alltime | all time | at high | at high | >+9999.0% | at high | >+9999.0% |
Arcutis Biotherapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.43 M(+308.0%) | $2.53 M(+70.6%) |
| June 2024 | - | $351.00 K(-2.0%) | $1.48 M(-2.3%) |
| Mar 2024 | - | $358.00 K(-7.0%) | $1.52 M(-0.3%) |
| Dec 2023 | $1.52 M(+62.8%) | $385.00 K(-0.5%) | $1.52 M(+2.6%) |
| Sept 2023 | - | $387.00 K(+0.3%) | $1.48 M(+7.6%) |
| June 2023 | - | $386.00 K(+6.3%) | $1.38 M(+20.1%) |
| Mar 2023 | - | $363.00 K(+4.6%) | $1.15 M(+22.8%) |
| Dec 2022 | $934.00 K(+105.7%) | $347.00 K(+23.0%) | $934.00 K(+29.2%) |
| Sept 2022 | - | $282.00 K(+81.9%) | $723.00 K(+29.8%) |
| June 2022 | - | $155.00 K(+3.3%) | $557.00 K(+10.1%) |
| Mar 2022 | - | $150.00 K(+10.3%) | $506.00 K(+11.5%) |
| Dec 2021 | $454.00 K | $136.00 K(+17.2%) | $454.00 K(+28.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $116.00 K(+11.5%) | $353.00 K(+32.2%) |
| June 2021 | - | $104.00 K(+6.1%) | $267.00 K(+38.3%) |
| Mar 2021 | - | $98.00 K(+180.0%) | $193.00 K(+58.2%) |
| Dec 2020 | $122.00 K(+79.4%) | $35.00 K(+16.7%) | $122.00 K(+9.9%) |
| Sept 2020 | - | $30.00 K(0.0%) | $111.00 K(+11.0%) |
| June 2020 | - | $30.00 K(+11.1%) | $100.00 K(+40.8%) |
| Mar 2020 | - | $27.00 K(+12.5%) | $71.00 K(+4.4%) |
| Dec 2019 | $68.00 K(>+9900.0%) | $24.00 K(+26.3%) | $68.00 K(+54.5%) |
| Sept 2019 | - | $19.00 K(+1800.0%) | $44.00 K(+76.0%) |
| June 2019 | - | $1000.00(-95.8%) | $25.00 K(+4.2%) |
| Mar 2019 | - | $24.00 K | $24.00 K |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual D&A year-on-year change?
- What is Arcutis Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
- What is Arcutis Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM D&A year-on-year change?
What is Arcutis Biotherapeutics annual depreciation & amortization?
The current annual D&A of ARQT is $1.52 M
What is the all time high annual D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual depreciation & amortization is $1.52 M
What is Arcutis Biotherapeutics annual D&A year-on-year change?
Over the past year, ARQT annual depreciation & amortization has changed by +$587.00 K (+62.85%)
What is Arcutis Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of ARQT is $1.43 M
What is the all time high quarterly D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly depreciation & amortization is $1.43 M
What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
Over the past year, ARQT quarterly depreciation & amortization has changed by +$1.04 M (+270.03%)
What is Arcutis Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of ARQT is $2.53 M
What is the all time high TTM D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM depreciation & amortization is $2.53 M
What is Arcutis Biotherapeutics TTM D&A year-on-year change?
Over the past year, ARQT TTM depreciation & amortization has changed by +$1.04 M (+70.33%)